471 related articles for article (PubMed ID: 35280677)
1. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
[TBL] [Abstract][Full Text] [Related]
2. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY
Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004
[TBL] [Abstract][Full Text] [Related]
3. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
4. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
Yu XT; Xu YF; Huang YF; Qu C; Xu LQ; Su ZR; Zeng HF; Zheng L; Yi TG; Li HL; Chen JP; Zhang XJ
PLoS One; 2018; 13(3):e0194069. PubMed ID: 29538417
[TBL] [Abstract][Full Text] [Related]
5. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376
[TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M
Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293
[TBL] [Abstract][Full Text] [Related]
8. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
[TBL] [Abstract][Full Text] [Related]
9. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway.
Wang X; Liang F; Dai Z; Feng X; Qiu F
J Ethnopharmacol; 2024 Jan; 318(Pt B):117050. PubMed ID: 37595814
[TBL] [Abstract][Full Text] [Related]
10.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
11. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
Li MX; Li MY; Lei JX; Wu YZ; Li ZH; Chen LM; Zhou CL; Su JY; Huang GX; Huang XQ; Zheng XB
Phytomedicine; 2022 Jun; 100():154052. PubMed ID: 35344714
[TBL] [Abstract][Full Text] [Related]
12. Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis.
Zhao X; Cui D; Yuan W; Chen C; Liu Q
Bioengineered; 2022 Mar; 13(3):7392-7409. PubMed ID: 35259053
[TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
14. Ethanol extract of Centella asiatica alleviated dextran sulfate sodium-induced colitis: Restoration on mucosa barrier and gut microbiota homeostasis.
Li H; Chen X; Liu J; Chen M; Huang M; Huang G; Chen X; Du Q; Su J; Lin R
J Ethnopharmacol; 2021 Mar; 267():113445. PubMed ID: 33022343
[TBL] [Abstract][Full Text] [Related]
15. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner.
Li Q; Cui Y; Xu B; Wang Y; Lv F; Li Z; Li H; Chen X; Peng X; Chen Y; Wu E; Qu D; Jian Y; Si H
Pharmacol Res; 2021 Aug; 170():105694. PubMed ID: 34087350
[TBL] [Abstract][Full Text] [Related]
16. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism.
Sun X; Zhang Y; Cheng G; Zhu T; Zhang Z; Xiong L; Hu H; Liu H
Biomed Pharmacother; 2023 Nov; 167():115430. PubMed ID: 37683590
[TBL] [Abstract][Full Text] [Related]
17. Berberine regulates intestinal microbiome and metabolism homeostasis to treat ulcerative colitis.
Yang T; Qin N; Liu F; Zhao Y; Liu W; Fan D
Life Sci; 2024 Feb; 338():122385. PubMed ID: 38184271
[TBL] [Abstract][Full Text] [Related]
18. The potential mechanism of qinghua quyu jianpi decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation.
Qu F; Li D; Zhang S; Zhang C; Shen A
J Ethnopharmacol; 2023 Jun; 310():116396. PubMed ID: 36933873
[TBL] [Abstract][Full Text] [Related]
19. Matrine protects against DSS-induced murine colitis by improving gut barrier integrity, inhibiting the PPAR-α signaling pathway, and modulating gut microbiota.
Yao H; Shi Y; Yuan J; Sa R; Chen W; Wan X
Int Immunopharmacol; 2021 Nov; 100():108091. PubMed ID: 34474274
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.
Chen S; Chen Z; Wang Y; Hao W; Yuan Q; Zhou H; Gao C; Wang Y; Wu X; Wang S
J Adv Res; 2022 Sep; 40():263-276. PubMed ID: 36100331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
